Understanding the FDA ANDA Process: How Generic Drugs Get Approved
Learn how the FDA's Abbreviated New Drug Application (ANDA) process works to bring affordable generic drugs to market by proving therapeutic equivalence.
Read morePopular post
Tag: Hatch-Waxman Act
Tentative Approval and Litigation: How Generic Drug Companies Wait for Market Entry
Tentative approval from the FDA lets generic drug makers prepare for market entry while patents expire-but it’s not the end of the road. Missing deadlines or mismanaging litigation can cost millions.
Read more
Paragraph IV Certifications: How Generic Drug Makers Challenge Patents Before Launch
Paragraph IV certifications let generic drug makers challenge brand-name patents before launch, speeding up access to cheaper medicines. This legal tool under the Hatch-Waxman Act has saved U.S. consumers over $2 trillion since 1984.
Read more